Abstract
The aim of the present research work was to develop and evaluate provesicular topical drug delivery system of indomethacin. The encapsulation of drug in vesicular structure prolongs the existence of the drug in the systemic circulation with improved bioavailability. The potential of proniosomes as a topical drug delivery system was explored by formulating proniosomal gel of indomethacin using coacervation-phase separation method with different ratios of sorbitan fatty acid esters (Span 60) and cholesterol. The formulations were characterized for various parameters like vesicle size and shape, drug entrapment, in vitro drug release profiles and vesicular stability at different storage conditions. In-vitro studies showed slow and sustained release of entrapped indomethacin. Stability studies for optimized proniosomal gel were conducted for 3 months. The current research work demonstrated that proniosomes are stable and promising topical drug delivery system for indomethacin.
Keywords: Gel, indomethacin, in-vitro release, proniosomes, stability studies, topical delivery.
Drug Delivery Letters
Title:Novel Vesicular Drug Delivery System for Topical Delivery of Indomethacin
Volume: 5 Issue: 1
Author(s): Harshal A. Pawar, Stutika S. Mane and Vibhavari B. Attarde
Affiliation:
Keywords: Gel, indomethacin, in-vitro release, proniosomes, stability studies, topical delivery.
Abstract: The aim of the present research work was to develop and evaluate provesicular topical drug delivery system of indomethacin. The encapsulation of drug in vesicular structure prolongs the existence of the drug in the systemic circulation with improved bioavailability. The potential of proniosomes as a topical drug delivery system was explored by formulating proniosomal gel of indomethacin using coacervation-phase separation method with different ratios of sorbitan fatty acid esters (Span 60) and cholesterol. The formulations were characterized for various parameters like vesicle size and shape, drug entrapment, in vitro drug release profiles and vesicular stability at different storage conditions. In-vitro studies showed slow and sustained release of entrapped indomethacin. Stability studies for optimized proniosomal gel were conducted for 3 months. The current research work demonstrated that proniosomes are stable and promising topical drug delivery system for indomethacin.
Export Options
About this article
Cite this article as:
Pawar A. Harshal, Mane S. Stutika and Attarde B. Vibhavari, Novel Vesicular Drug Delivery System for Topical Delivery of Indomethacin, Drug Delivery Letters 2015; 5 (1) . https://dx.doi.org/10.2174/2210303104666141031003625
DOI https://dx.doi.org/10.2174/2210303104666141031003625 |
Print ISSN 2210-3031 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-304X |
Call for Papers in Thematic Issues
Nanomaterial Assisted Targeted Therapies for Chronic Disorders- Preclinical to Clinical Outcomes
In recent years, the integration of nanomaterials into therapeutic strategies has emerged as a promising avenue in the pursuit of more effective treatments for chronic disorders. This dynamic field, explored in the context of "Nanomaterial Assisted Targeted Therapies for Chronic Disorders - Preclinical to Clinical Outcomes," seeks to bridge the ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Anabolic Effects of Growth Hormone (GH) and GH Secretagogues on Bone Mass and Density
Medicinal Chemistry Reviews - Online (Discontinued) The Role of Phospholipase D Enzyme(s) in Modulating Cell Signaling: Implications for Cancer Drug Development
Current Bioactive Compounds Effect of Piperine, Quercetin, Polysorbate 80 on the Oral Bioavailability of Losartan in Male Wistar Rats
Pharmaceutical Nanotechnology Approaches to Optimize Gene Therapy for the Treatment of Hematologic Malignancies: Overcoming the Obstacles
Current Gene Therapy Intestinal Targeting of Drugs: Rational Design Approaches and Challenges
Current Topics in Medicinal Chemistry Inhibitors of Serine/Threonine Protein Phosphatases: Biochemical and Structural Studies Provide Insight for Further Development
Current Medicinal Chemistry Molecular Interplay between Platelets and the Vascular Wall in Thrombosis and Hemostasis
Current Vascular Pharmacology Current Advances in Vehicles for Brain Gene Delivery
Current Gene Therapy Development of Patents and Clinical Trials on Regenerative Therapy: Gene Therapy
Recent Patents on Regenerative Medicine Spherical Self-Organizing Map Detects MYBL 1 As Candidate Gene for Triple-Negative Breast Cancer
Neuroscience and Biomedical Engineering (Discontinued) Strategies for Overcoming Inherent and Acquired Resistance to EGFR Inhibitors by Targeting Downstream Effectors in the RAS/PI3K Pathway
Current Cancer Drug Targets Targeting Type 1 Diabetes Before and at the Clinical Onset of Disease
Endocrine, Metabolic & Immune Disorders - Drug Targets P-Glycoprotein Mediated Multidrug Resistance Reversal by Phytochemicals: A Review of SAR & Future Perspective for Drug Design
Current Topics in Medicinal Chemistry Natural Products to Improve Quality of Life Targeting for Colon Drug Delivery
Current Drug Delivery Microarray: An Approach for Current Drug Targets
Current Drug Metabolism Pharmacological Modulation of Sphingolipids and Role in Disease and Cancer Cell Biology
Mini-Reviews in Medicinal Chemistry Targeting of Antioxidant and Anti-Thrombotic Drugs to Endothelial Cell Adhesion Molecules
Current Pharmaceutical Design Thymoquinone Anticancer Discovery: Possible Mechanisms
Current Drug Discovery Technologies Procyanidins and Their Healthy Protective Effects Against Type 2 Diabetes
Current Medicinal Chemistry Cellular and Biochemical Alterations Caused by Artificial Depletion of Glutathione
Current Enzyme Inhibition